Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Purpose: Gene expression tests can inform decisions on whether to recommend chemotherapy for patients with HR+, HER2- early breast cancer. The goal of this analysis was to compare treatment costs by an expanded budget impact model of reimbursed gene expression tests in Germany. Methods: A cost compa...

Full description

Bibliographic Details
Main Authors: M.P. Lux, C. Minartz, H. Müller-Huesmann, M.F. Sandor, K.H. Herrmann, S. Radeck-Knorre, A.S. Neubauer
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Oncotype DX
Chemotherapy
Budget impact
Gene expression test
Breast cancer
Overtreatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000119

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222000119

Similar Items